|
ZNF549 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62594999999488E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.179030E-04 |
| Normal-vs-Stage2 |
3.757800E-02 |
| Normal-vs-Stage3 |
2.80620000003839E-06 |
| Normal-vs-Stage4 |
1.98374650040023E-12 |
| Stage1-vs-Stage2 |
8.257400E-01 |
| Stage1-vs-Stage3 |
2.491900E-02 |
| Stage1-vs-Stage4 |
1.30870003722805E-09 |
| Stage2-vs-Stage3 |
1.778180E-01 |
| Stage2-vs-Stage4 |
1.202410E-03 |
| Stage3-vs-Stage4 |
3.120300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44450000003371E-06 |
| Normal-vs-AfricanAmerican |
2.380000E-03 |
| Normal-vs-Asian |
9.622300E-03 |
| Caucasian-vs-AfricanAmerican |
6.214600E-01 |
| Caucasian-vs-Asian |
7.968600E-01 |
| AfricanAmerican-vs-Asian |
6.847000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.15049999994366E-07 |
| Normal-vs-Female |
3.073900E-02 |
| Male-vs-Female |
8.251600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.025500E-04 |
| Normal-vs-Extreme_Weight |
2.3392000000344E-06 |
| Normal-vs-Obese |
7.837000E-03 |
| Normal-vs-Extreme_Obese |
2.917900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.644600E-01 |
| Normal_Weight-vs-Obese |
2.855600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.905200E-01 |
| Extreme_Weight-vs-Obese |
1.103600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.991800E-01 |
| Obese-vs-Extreme_Obese |
3.127800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.139090E-03 |
| Normal-vs-Age(41-60Yrs) |
3.263000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.41069999995513E-06 |
| Normal-vs-Age(81-100Yrs) |
3.81540000005121E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.069000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.392400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.097400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.269900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.886500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.225010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.602600E-04 |
| Normal-VS-Type2 PRCC |
5.09320030595006E-10 |
| Normal-VS-KIRP CIMP |
2.577500E-03 |
| Normal-VS-Unclassified PRCC |
1.961500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.65080000003037E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.910800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.935200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.893200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.655700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.749000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31370000433506E-08 |
| Normal-vs-N1 |
4.14880000000339E-05 |
| Normal-vs-N2 |
1.68668999999122E-05 |
| N0-vs-N1 |
9.643200E-01 |
| N0-vs-N2 |
1.439160E-01 |
| N1-vs-N2 |
2.366400E-01 |
|
|
